Blood test could predict severity of multiple sclerosis
Mark Henderson, Science Editor
August 31, 2009
Patients whose MS is thought likely to progress quickly could be started swiftly on therapies that can reduce the frequency and severity of attacks, while those at lower risk could be spared medication they do not need immediately. More accurate ways of assessing prognosis could also help to prepare patients for what they should expect in the future, removing the uncertainty that can be a distressing feature of the disease.
Read the full article
Dr. Rachel Farrell, of the Institute of Neurology at University College London, is the principal investigator.